Company Lotus Ventures Inc.

J

CA54571Q1081

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Alternative Medicine

Market Closed - Canadian Securities Exchange Other stock markets 12:37:16 2024-03-28 EDT			5-day change	1st Jan Change
0.01 ^CAD	-.--%		-.--%	-33.33%

2023	Lotus Ventures Inc. Launches Joker Juice Cannabis Strain in BC	CI
2023	Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2023	CI

Lotus Ventures Inc. is a Canada-based licensed cannabis producer and owner of the Lotus Cannabis Co. brand. The Company primarily cultivates cannabis flowers, which are sold in the wholesale, recreational, and medical markets across Canada. The Company owns and operates a 22,500 square foot indoor cannabis production facility in Armstrong, British Columbia and holds the licenses for cultivation and sale of cannabis in Canada. It has grown several cultivars, including the Keylime Kush, Black Blossom, Tranquil Elephantizer, and Kalifornia. Its Keylime Kush recreational portfolio includes 3.5 gram flower, 14 gram flower, and 3 x 0.5 gram pre-rolls. The Company sells its flagship product, the Keylime Kush, to over 300 retail stores across British Columbia and Ontario.

CAD in Million	2022	Weight	2023	Weight	Delta
Cannabis 100.0 %	2	100.0 %	2	100.0 %	+18.25%

CAD in Million	2022	Weight	2023	Weight	Delta
Canada 100.0 %	2	100.0 %	2	100.0 %	+18.25%

Managers	Title	Age	Since
Dale McClanaghan CEO	Chief Executive Officer	-	14-11-26
Gavin Dew DFI	Director of Finance/CFO	-	-
Carl Correia COO	Chief Operating Officer	42	14-11-26
Daniel McRobert IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Dale McClanaghan CEO	Chief Executive Officer	-	14-11-26
Carl Correia COO	Chief Operating Officer	42	14-11-26
Simon Davie BRD	Director/Board Member	-	19-03-19
Maurice Creagh BRD	Director/Board Member	-	19-07-13

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	89,969,799	75,101,967 ( 83.47 %)	0	83.47 %

Name	Equities	%	Valuation
Dale McClanaghan 8.767 %	7,887,332	8.767 %	228 733 $
Carl Correia 5.260 %	4,732,500	5.260 %	137 243 $
Simon Davie 1.917 %	1,725,000	1.917 %	50 025 $
Maurice Creagh 0.5813 %	523,000	0.5813 %	15 167 $

Lotus Ventures, Inc.

1030 West Georgia Street Suite 1010

V6E 2Y3, Vancouver

+604 644 9844

http://lotuscannabis.ca

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Alternative Medicine

	1st Jan change	Capi.
LOTUS VENTURES INC.	-33.33%	838K
DONG-E-E-JIAO CO.,LTD.	+39.33%	6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-18.38%	4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.17%	3.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.98%	3.16B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.41%	2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+48.74%	1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-4.82%	1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-1.24%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.96%	1.6B

Alternative Medicine